Вход в систему


Главная

14th World Congress on Cancers of the Skin

сб., 05/05/2012 - 14:38 — Y.Y.Sergeev (нет)
1 авг 2012 - 00:00
4 авг 2012 - 23:59
America/Sao_Paulo

14th World Congress on Cancers of the Skin will take place in Sao-Paolo, Brazil, from August 1-4, 2012. The Congress will have a multidisciplinary character to offer a highly scientific program covering all the fields of skin cancer. The central line of the Congress will focus on the latest advances in prevention, identification and treatment of skin cancer.

Scientific Program
Wednesday, 1 August
08.00 – 15.30 — XII DERMOSCOPY COURSE OF HOSPITAL A. C. CAMARGO
Auditorium 1 – Hotel Caesar Business
  • 08.00 – 08.20 Dermoscopy technique and devices: polarized X non-polarized – Susana Puig (Spain)
  • 08.20 – 08.40 Dermoscopic criteria standardization: results of consensus meeting of IDS – Josep Malvehy (Spain)
  • 08.40 – 09.00 Pattern Analysis Revisited: The Beauty and Beast Sign – Julia Casagrande (Brazil)
  • 09.00 – 09.20 Dermoscopy lessons on nevogenesis – Giovanni Pellacani (Italy)
  • 09.20 – 09.40 Spitz Nevus and Congenital Nevus - Francisco M. Paschoal (Brazil)
  • 09.40 – 10.00 Vascular Structures by Dermoscopy - Susana Puig (Spain)
  • 10.10 – 10.30 COFFEE BREAK
  • 10.30 – 10.50 Dermoscopy of non-melanocytic skin tumors – Horacio Cabo (Argentina)
  • 10.50 – 11.10 “Dying Nevus” X Regressing Melanoma - Giovanni Pellacani (Italy)
  • 11.10 – 11.30 Recurrent Naevi X Recurrent Melanomas - Josep Malvehy (Spain)
  • 11.30 – 11.50 Pigmented  and Thin Nodular Melanomas – how to recognize – Susana Puig (Spain)
  • 11.50 – 12.10 Dermoscopy usefulness to detection Facial Lentigo Maligna. - Gisele Gargantini Rezze (Brazil)
  • 12.10 – 13.10 LUNCH
  • 13.10 – 13.30 Melanonychia Striata – dermoscopy assessment. - Sergio Hirata (Brazil)
  • 13.30 – 13.50 Dermoscopy patterns of acral benign and malignant lesions. - Juliana Machado (Brazil)
  • 13.50 – 14.10 Dermoscopy of Pigmented Lesions of the Mucosa – Horacio Cabo (Argentina)
  • 14.10 – 14.30 Multiple Nevi Patients and Digital Dermoscopy: Management Recommendation. – Bianca Costa Soares de Sá (Brazil)
  • 14.30 – 15.30 Interactive Session – Susana Puig (Spain) / Josep Malvehy (Spain) / Giovanni Pellacani (Italy)
16.00 – 17.40 — SYMPOSIUM 1 — Skin Cancer Prevention: how are we doing?
Auditorium 1
  • 16.00 – 16.10 Introduction – Perry Robins (USA)
  • 16.10 – 16.25 Why is skin cancer incidence rising around the world? – Darrel Rigel (USA)
  • 16.25 – 16.40 Photoprotection as practiced is effective in preventing skin cancer? – Fernando Stengel (Argentina)
  • 16.40 – 16.55 Vitamin D, tanning, and skin cancer: what shall we tell our patients. – James Spencer (USA)
  • 16.55 – 17.10 Ban artificial tanning is an effective measure? – Isabel Longo (Spain)
  • 17.10 – 17.25 Skin Cancer: Brazilian National Programme. - Marcus Maia (Brazil)
  • 17.25 – 17.40 EPIDERM: EU-project against skin cancer. – Eggert Stockfleth (Germany)
17.40 – 18.40 — SYMPOSIUM 2
Auditorium 1
  • 17.40 – 18.10 Signaling pathway and skin cancer. – Brigitte Dréno (France)
  • 18.10 – 18.40 CTLA-4 Antibody based treatment for skin cancer. – Caroline Robert (France)
18.40 – 19.10 — SATELLITE SYMPOSIUM – ISDIN
19.10 – Welcome Cocktail
Thursday, 2 August
08.00 – 09.50 — SYMPOSIUM 3 — Non melanoma Skin Cancer
Auditorium 1
  • 08.00 – 08.15 The concept of field of cancerization. – Eggert Stockfleth (Germany)
  • 08.17 – 08.32 Radiation therapy for skin cancer. – James Spencer (USA)
  • 08.34 – 08.49 Targeted therapy for Basal Cell Carcinoma. – Rogerio Neves (USA)
  • 08.51 – 09.06 Optical coherence tomography for the imaging of non-melanocytic cutaneous tumors. – Ana Maria Forsea (Romania)
  • 09.08 – 09.28 Defining and management of High-Risk Cutaneous Squamous Cell Carcinoma. – Alvaro Acosta (Colombia)
  • 09.30 – 09.45 Non melanoma skin cancer: precursor and progression. – Giovanni Pellacani (Italy)
08.00 – 09.50 — SYMPOSIUM 4 – Familial Melanoma and Dysplastic Nevus Syndrome
Auditorium 2
  • 08.00 – 08.15 Clinical aspects of dysplastic nevus syndrome and familial melanoma. - Bianca Sá (Brazil)
  • 08.15 – 08.30 Pathological aspects of melanocytic dysplasia. – Gilles Landman (Brazil)
  • 08.30 – 08.45 Genetic assessment in familial melanoma. – Susana Puig (Spain)
  • 08.45 – 09.00 Familial melanoma in Latin America. - Horacio Cabo (Argentina)
  • 09.00 – 09.30 Discussion
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special lecture 1
Auditorium 1
  • 10.30 – 11.00 Targeted therapy for melanoma. - Caroline Robert (France)
11.00 – 12.20 — SYMPOSIUM 5 — Nonmelanoma Skin Cancer
Auditorium 1
  • 11.00 – 11.20 Overview of vitamin D, health and current recommendations. - Henry Lim (USA)
  • 11.20 – 11.35 New therapy for Squamous Cell Carcinoma. - Maritza Perez (USA)
  • 11.35 – 11.50 Topical treatments of epithelial cancers: an update. – William Hanke (USA)
  • 11.50 – 12.05 Dermoscopy of nonmelanoma skin cancer: what’s new? – Horacio Cabo (Argentina)
  • 12.05 – 12.20 Delayed treatment of nonmelanoma skin cancer. – Leonard Goldberg (USA)
11.00 – 12.20 — CASES PRESENTATION 1
Auditorium 2
  • Dermoscopy / Confocal / Histopathology
  • Martin Mihm (USA)
  • Gilles Landman (Brazil)
  • Giovanni Pellacani (Italy)
  • Miriam Nacagami (Brazil)
  • Martin Sangueza (Bolivia)
  • Alistar Cochan (USA)
  • Francisco Paschoal (Brazil)
12.20 – 12.50 — OFFICIAL OPENING
Auditorium 1
13.00 – 13.50 — SATELLITE SYMPOSIUM – BIOLAB
13.00 – 13.50 — SATELLITE SYMPOSIUM – MERCK
12.50 – 14.00 — LUNCH/Poster
14.00 – 15.30 — SYMPOSIUM 6 — Rare tumors of the skin
Auditorium 1
  • 14.00 – 14.13 Merkel cell carcinoma: new insights in prognostic  markers (VEGF, cKIT, etc) – the role of pathology. – Jane Messina (USA)
  • 14.15 – 14.28 Isolate limb perfusion (ILP) for Merkel cell carcinoma. - Andrea Cavalcanti (France)
  • 14.30 – 14.43 Are cutaneous adnexal tumors markers of internal malignancy? – Mai P. Hoang (USA)
  • 14.45 – 14.58 Cutaneous angiomatous lesions of interest for dermatologist. – Omar Sangueza (USA)
  • 15.00 – 15.15 Diagnosis and treatment of B-cell lymphomas. – Robert Knobler (Austria)
  • 15.17 – 15.30 Is there standardized surgical treatment of primary lesion of Merkel carcinoma which is universally accepted? – Francisco Belfort (Brazil)
14.00 – 15.30 — CASES PRESENTATION 2
Auditorium 2
  • Dermoscopy / Confocal / Histopatology
  • Martin Mihm (USA)
  • Gilles Landman (Brazil)
  • Giovanni Pellacani (Italy)
  • Miriam Nacagami (Brazil)
  • Adriano Piris (USA)
  • Horacio Cabo (Argentina)
  • Martin Sangueza (Bolivia)
  • Alistar Cochan (USA)
  • Josep Malvhey (Spain)
15.30 – 16.00 — Special Lecture 2
Auditorium 1
  • Challenges, limitations and frontiers of melanoma immunotherapy. – Brigitte Dréno (France)
16.00 – 16.30 — Coffee Break
16.30 – 18.30 — SYMPOSIUM 7 — Cutaneous Lymphoma
Auditorium 1
  • 16.30 – 16.45 Mycosis fungoides:is imunohistochemical evaluation always diagnostic? – Sergio Gonzales (Chile)
  • 16.45 – 17.00 Update on the EORTC Treatment Platform for Treatment of CTCL – Robert Knobler (Austria)
  • 17.00 – 17.15 Extranodal NK/T – cell lymphoma, nasal type. - José Antonio Sanches (Brazil)
  • 17.15 – 17.30 Extracorporeal Photopheresis and CTCL. – Robert Knobler (Austria)
  • 17.30 – 17.45 ATLL Are There Primary Cutaneous Forms? – Achilea Bittencourt (Brazil)
  • 17.45 – 18.00 Hidroa vacciniforme like lymphoma. – Francisco Bravo (Peru)
  • 18.00 – 18.15 Mycosis fungoides - Treatment of Advanced Stages. - Larissa Geskin (USA)
  • 18.15 – 18.30 Discussion
16.30 – 18.40 — SYMPOSIUM 8 — Mohs Surgery
Auditorium 2
  • 16.30 – 16.44 Technical Variations of Mohs Surgery. – Leonard Goldberg (USA)
  • 16.46 – 17.00 Lesions on rare locations. – Abel Gonzales (Argentina)
  • 17.02 – 17.16 Mohs Surgery of adnexial tumors. – Eugenio Pimentel (Brazil)
  • 17.18 – 17.30 Mohs of Squamous Cell Carcinoma and Basal Cell Carcinoma. – Joseph Alcalay (Israel)
  • 17.32 – 17.44 Mohs Surgery On Dermatofibrossarcoma Protuberans. – Alvaro Acosta (Colombia)
  • 17.46 – 18.00 Controversies in Mohs Surgery.
  • 18.02 – 18.16 Multidisciplinaire approach on difficult cases. - Selma Cernea (Brazil)
  • 18.18 – 18.32 Mohs lab. How to improve time work. – Gaston Galimberti (Argentina)
Friday, 3 August
08.00 – 10.00 — SYMPOSIUM 9 — Skin Cancer: a multidisciplinary approach
Auditorium 1
  • 08.00 – 08.20 Mohs surgery for melanoma in situ. – Joseph Alcalay (Israel)
  • 08.20 – 08.35 Melanonyquia Striata. - Sergio Hirata (Brazil)
  • 08.35 – 08.50 Sentinel lymph node biopsy: an update. – Alistar Cochan (USA)
  • 08.50 – 09.05 Influence of the mitotic index in the treatment of cutaneous melanoma. – João Duprat (Brazil)
  • 09.05 – 09.20 Surgery guided by confocal mycroscopy. – Josep Malvehy (Spain)
  • 09.20 – 09.35 Electrochemotherapy with bleomycin. – John Thompson (Australia)
  • 09.35 – 09.50 One Hundred thirty consecutive isolate limb perfusion (ILP) in melanoma patients with in-transit metastases.- Andrea Cavalcanti (France)
  • 09.50 – 10.00 Discussion
08.00 – 10.00 — SYMPOSIUM 10 — Cutaneous Sarcomas and other Neoplasms
Auditorium 2
  • 08.00 – 08.15 Molecular tools for diagnosing Dermatofibrossarcoma: new insigts regarding treatment with targed therapy. – Isabela Wernek (Brazil)
  • 08.15 – 08.30 Dermatofibrosarcoma protuberans: analysis of different surgical techniques and use of Imatinib. - Rogerio Neves (USA)
  • 08.30 – 08.45 Molecular Pathology in Cutaneous Sarcomas. – Alexander J. Lazar (USA)
  • 08.45 – 09.00 Diagnosis and Treatment of Cutaneous Leiomyosarcoma. – Rogerio Neves (USA)
  • 09.00 – 09.15 Angiossarcoma. – Omar Sangueza (USA)
  • 09.15 – 09.30 Superficial Malignant Fibrous Histiocytoma. – Rogerio Neves (USA)
  • 09.30 – 10.00 Discussion
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special lecture 3
Auditorium 1
  • Cutaneous lymphoma: new aspects. – Larissa Geskin (USA)
11.00 – 12.30 — SYMPOSIUM 11 — Skin Cancer in Immunocompromised
Auditorium 1
  • 11.00 – 11.15 Skin cancer in organ transplant patients: epidemilogic and pathogenic aspects. - Claus Garbe (Germany)
  • 11.17 – 11.32 How to prevent skin tumors in immunocompromised patients? – Isabel Longo (Spain)
  • 11.34 – 11.49 Epidermodysplasia Verruciformis and skin cancer. - Walmar Roncalli Pereira de Oliveira (Brazil)
  • 11.51 – 12.04 Management of epithelial cell carcinomas in transplant patients. – Eggert Stockfleeth (Germany)
  • 12.06 – 12.21 Histopathological features of skin lesions in xeroderma pigmentosum. – Adriano Piris (USA)
11.00 – 12.30 — CASES PRESENTATION 3
Auditorium 2
  • Dermoscopy / Confocal / Histopatology
  • Susana Puig (Spain)
  • Josep Malvhey (Spain)
  • Rute Lellis (Brazil)
  • Juan Maceira (Brazil)
  • Omar Sangueza (USA)
12.30 – 13.15 — SATELLITE SYMPOSIUM – LEO PHARMA
12.30 – 14.00 — LUNCH / POSTER
14.00 – 15.30 — SYMPOSIUM 12 — Melanocytic Nevus
Auditorium 1
  • 14.00 – 14.12 Nevogenesis: dermascopy and confocal microscopy insigths. – Giovanni Pellacani (Italy)
  • 14.14 – 14.26 What is best practice management of the patient with multiple moles? - Claus Garbe (Germany)
  • 14.28 – 14.40 Large congenital melanocytic nevi: clinical experience. - Flávia Bittencourt (Brazil)
  • 14.42 – 14.54 Spitizoid lesion: pathology and management in the molecular era. – Martin Mihm (USA)
  • 14.56 – 15.08 Follow up strategies for nevi: is it still of interest? – Jean-Jacques Grob (France)
  • 15.10 – 15.22 Dermoscopy and confocal microscopy in atypical nevus. – Giovanni Pellacani (Italy)
14.00 – 15.30 — SYMPOSIUM 13 — Tumors of the nail apparatus
Auditorium 2
  • 14:00 – 14:20 – Retrospective study of nail epidermoid carcinomas diagnosed in the department of dermatopathology of the St Pierre hospital over a 15 years period. - Bertrand Richert (Belgium)
  • 14:20 – 14:40 – Surgical treatment of nail melanoma. - Eckart Haneke (Germany)
  • 14:40 – 15:00 – Dermoscopy as a diagnostic tool for nail melanoma. – Nilton Di Chiacchio (Brazil)
  • 15:00 – 15:20 – Management of unusual malignant nail tumors. - Walter Refkalefsky Loureiro (Brazil)
  • 15:20 – 15:30 – Q&A

14.00 – 15.30 — FREE COMUNICATION
Auditorium 3
15.30 – 16.00 — Special Lecture 4
Auditorium 1
  • Cutaneous side effects and new drugs: how to manage? Caroline Robert (France)
16.00 – 16.30 — Coffee Break
16.30 – 18.30 — SYMPOSIUM 14 — Melanoma
Auditorium 1
  • 16.30 – 16.43 Prevention of melanoma with regular sunscreen use. – Darrel Rigel (USA)
  • 16.45 – 16.58 Treatment of locally advanced melanoma. - Alberto Wainstein (Brazil)
  • 17.00 – 17.13 Correlation between dermoscopic patterns, histological type and prognostic factors. - Francisco Paschoal (Brazil)
  • 17.15 – 17.28 Melanomas detected in a follow-up program. – Susana Puig (Spain)
  • 17.30 – 17.43 Lymphonodectomy indication for sentinel node positive. – John Thompson (Australia)
  • 17.45 – 17.58 Evaluation of lymph node by ultrasound on Cutaneous Melanoma. - Miguel Brandão (Brazil)
  • 18.00 – 18.13 Molecular and genetic techniques as adjuncts to histology: is it in daily practice? – Alistair Cochran (USA)
  • 18.15 – 18.28 Melanocytic tumors of uncertain biological behavior (Epitheliod pigmented melanocytoma, Spitzoid tumors). – Adriano Piris (USA)
16.30 – 18.30 — FREE COMUNICATION
Auditorium 2
Saturday, 4 August
08.00 – 10.00 — SYMPOSIUM 15 — Cutaneous Melanoma
Auditorium 1
  • 08.00 – 08.13 New insights in therapy of melanoma: the role of pathology. – Martin Mihm (USA)
  • 08.15 – 08.28 Possibility of frozen in SLN biopsy. Pros and cons. – Ivan Abranches (Brazil)
  • 08.30 – 08.43 Sentinel lymph node: prognosis or therapeutic? – John Thompsom (Australia)
  • 08.45 – 08.58 Genetic counseling in melanoma patients. – Susana Puig (Spain)
  • 09.00 – 09.13 Thin melanomas: analysis of microvessel density. - Helena O. da Costa (Brazil)
  • 09.15 – 09.28 Anti angiogenic factors. – Hubert Pehamberger (Austria)
  • 09.30 – 09.43 Surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). – Jean-Jacques Grob (France)
  • 09.45 – 09.58 Epithelial tumors arising in patients submitted to targeted therapy for melanoma. – Jane Messina (USA)
08.30 – 10.00 — PATHOLOGY SYMPOSIUM 1
Auditorium 3
Coordinator – Gilles Landman (Brazil)
  • 8.30 – 9.00The pathology of targeted therapy side effects. -Jane Messina (USA) & Mai Hoang (USA)
  • 9.00 – 9.30The spectrum of Spitzoid lesions – what is the best approach for the patient and the physician? – Marthin Mihm (USA) & Jane Messina (USA)
  • 9.30 – 10.00Is molecular pathology ready to substitute the histopathological classification of melanomas? – Alistair Cochran (USA) & Martin Mihm (USA)
10.00 – 10.30 — Coffee Break
10.30 – 11.00 — Special Lecture 5
Auditorium 1
  • 10.30 – 11.00Imaging diagnoses of skin cancer: Current status and prospect futures. – Giovanni Pellacani (Italy)
11.00 – 13.00 — SYMPOSIUM 16 — Cutaneous Melanoma
Auditorium 1
  • 11.00 – 11.15Acral melanoma: is it going to benefit from molecular pathology? – Gilles Landman (Brazil)
  • 11.17 – 11.32Adjuvant therapy: lessons of the past. – Jean-Jacques Grob (France)
  • 11.34 – 11.49Locoregional treatment of melanoma. – John Thompson (Australia)
  • 11.51 – 12.06Optimum excision margins for melanoma. -  John Thompson (Australia)
  • 12.08 – 12.23The most impressive melanomas in Bolivia. – Martin Sangueza (Bolivia)
  • 12.25 – 12.40Advanced imaging evaluation in a melanoma unit. – Josep  Malvehy (Spain)
  • 12.45 – 13.00Rare melanomas: desmoplastic, melanoma of soft parts. – Martin Mihm (USA)
11.00 – 13.00 — PATHOLOGY SYMPOSIUM 2
Auditorium 3
Coordinator - Gilles Landman (Brazil)
11.00 – 11.30 Are we obliged to  search for mutations in the most common adnexal tumors associated with internal malignancy? - Mai Hoang (USA) & Alexander J. Lazar (USA)
11.30 – 12.00 Lentigo maligna – surgical margins and frozen section immunohistochemistry – yes or no? - Omar Sangueza (USA) & Juan Maceira (Brazil)
12.00 – 12.30 When should you trust molecular diagnosis in non-melanoma skin tumors? - Alexander J. Lazar (USA) & Sergio Gonzales (Chile)
12.30 – 13.00 Mycosis fungoides versus pseudolymphomatous T cell hyperplasia. Are the new drugs increasing pseudolymphomas? - Sergio Gonzales (Chile) & Omar Sangueza (USA)
13.00 — Closing
 

More information can be found on the official site of the Congress.